The Stryker hip recall of the company’s Rejuvenate and ABGII hip devices occurred in July, 2012. At the time of the Stryker hip recall Stryker noted that the combination of chromium, cobalt and titanium in the neck region of the recalled implants may fret and corrode, leading to serious medical conditions and chronic pain. The tiny metal shards released from the metal implants can inject themselves into the bloodstream of the implant recipient or can lodge within the tissue surrounding the hip. When the metal shards stop in the hip tissue, inflammation, infection and chronic pain can result. These symptoms are known as metallosis and are one reason for the Stryker hip recall.